| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.07 |